Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.1B |
| Sales growthchange from the year before | +28.8% |
| Gross marginshare of sales left after the direct cost of what it sells | 15.0% |
| Operating marginshare of sales left after running the business | 2.0% |
| Net marginshare of sales kept as profit | 2.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 5.9% |
| Return on invested capitalprofit made on each $100 put into the business | 11.1% |
| Return on equityprofit vs. shareholders' accounting value | 615.9% |
| Debt / equitydebt vs. shareholders' accounting value | 36.88 |
| Interest coverhow many times profit covers interest payments | 2.1x |
| Change in share countnegative = the company is buying back its shares | +25.9% |
2 insiders sold $2.5M (all under pre-arranged plans) on the open market.
| Nonko EugeneDirector | Sold (plan)Aug 5 | 10,445 shat $12.30 · $128K |
| Nonko EugeneDirector | Sold (plan)Aug 4 | 10,445 shat $12.46 · $130K |
| Yi StevenSee Remarks · Director | Sold (plan)Aug 3 | 72,000 shat $12.64 · $910K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy